Literature DB >> 16934304

Functional characterization and epitope analysis of a recombinant dermonecrotic protein from Loxosceles intermedia spider.

L Felicori1, S C Araujo, R A Machado de Avila, E F Sanchez, C Granier, E Kalapothakis, C Chávez-Olórtegui.   

Abstract

In the present study the recombinant form (recLiD1) of a dermonecrotic protein present in the Brazilian brown spider Loxosceles intermedia venom was expressed in Escherichia coli cells and purified by reversed-phase HPLC using a C8 Vydac column. About 25.8mg of purified recLiD1 was produced from a litre of bacterial culture. SDS/PAGE and immunoblot analysis of the recombinant protein revealed an apparent molecular weight of 32-35kDa. The later result was confirmed by mass spectrometry (32,758Da). recLiD1 displayed dermonecrotic and platelet aggregation activities which were qualitatively similar to that displayed by the crude L. intermedia venom. However, very low sphingomyelinase D enzymatic activity and complement-dependent haemolytic activities were observed. recLiD1 immunized BALB/c mice developed an antibody response. Anti-recLiD1 antibodies recognized L. intermedia venom in an indirect enzyme-linked immunosorbent assay (ELISA) and cross-reacted with crude venoms from L. intermedia, L. gaucho and L. laeta. An in vivo protection assay carried out 5 weeks after the end of the immunization protocol showed that 75% of the vaccinated mice could resist the challenge by 2.5LD(50) of L. intermedia venom. To characterize epitopes associated with protective antibodies, we prepare sets of immobilized synthetic 15 mer overlapping peptides covering the complete amino acid sequences of the recLiD1. Antibodies revealed one antigenic region in the N-terminal part of the toxin. The amino acid sequence of this epitope was found in several dermonecrotic proteins and some of its residues have been implicated with the active site of the toxin.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16934304     DOI: 10.1016/j.toxicon.2006.06.019

Source DB:  PubMed          Journal:  Toxicon        ISSN: 0041-0101            Impact factor:   3.033


  10 in total

1.  Molecular evolution, functional variation, and proposed nomenclature of the gene family that includes sphingomyelinase D in sicariid spider venoms.

Authors:  Greta J Binford; Melissa R Bodner; Matthew H J Cordes; Katherine L Baldwin; Melody R Rynerson; Scott N Burns; Pamela A Zobel-Thropp
Journal:  Mol Biol Evol       Date:  2008-11-28       Impact factor: 16.240

2.  Recombinant Protein Containing B-Cell Epitopes of Different Loxosceles Spider Toxins Generates Neutralizing Antibodies in Immunized Rabbits.

Authors:  Sabrina de Almeida Lima; Clara Guerra-Duarte; Fernanda Costal-Oliveira; Thais Melo Mendes; Luís F M Figueiredo; Daysiane Oliveira; Ricardo A Machado de Avila; Valéria Pereira Ferrer; Dilza Trevisan-Silva; Silvio S Veiga; João C Minozzo; Evanguedes Kalapothakis; Carlos Chávez-Olórtegui
Journal:  Front Immunol       Date:  2018-04-03       Impact factor: 7.561

Review 3.  Biotechnological potential of Phospholipase D for Loxosceles antivenom development.

Authors:  Matías Fingermann; Adolfo Rafael de Roodt; Osvaldo Cascone; María Victoria Miranda
Journal:  Toxicon X       Date:  2020-04-18

Review 4.  Innovative Immunization Strategies for Antivenom Development.

Authors:  Erick Bermúdez-Méndez; Albert Fuglsang-Madsen; Sofie Føns; Bruno Lomonte; José María Gutiérrez; Andreas Hougaard Laustsen
Journal:  Toxins (Basel)       Date:  2018-11-02       Impact factor: 4.546

Review 5.  Brown Spider (Loxosceles) Venom Toxins as Potential Biotools for the Development of Novel Therapeutics.

Authors:  Daniele Chaves-Moreira; Fernando Hitomi Matsubara; Zelinda Schemczssen-Graeff; Elidiana De Bona; Vanessa Ribeiro Heidemann; Clara Guerra-Duarte; Luiza Helena Gremski; Carlos Chávez-Olórtegui; Andrea Senff-Ribeiro; Olga Meiri Chaim; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2019-06-19       Impact factor: 4.546

6.  Loxoscelism: Advances and Challenges in the Design of Antibody Fragments with Therapeutic Potential.

Authors:  Sabrina Karim-Silva; Alessandra Becker-Finco; Isabella Gizzi Jiacomini; Fanny Boursin; Arnaud Leroy; Magali Noiray; Juliana de Moura; Nicolas Aubrey; Philippe Billiald; Larissa M Alvarenga
Journal:  Toxins (Basel)       Date:  2020-04-16       Impact factor: 4.546

7.  Immunomic Investigation of Holocyclotoxins to Produce the First Protective Anti-Venom Vaccine Against the Australian Paralysis Tick, Ixodes holocyclus.

Authors:  Manuel Rodriguez-Valle; Sonia McAlister; Paula M Moolhuijzen; Mitchell Booth; Kim Agnew; Claudia Ellenberger; Aleta G Knowles; Kathleen Vanhoff; Matthew I Bellgard; Ala E Tabor
Journal:  Front Immunol       Date:  2021-10-04       Impact factor: 7.561

8.  CPP-Ts: a new intracellular calcium channel modulator and a promising tool for drug delivery in cancer cells.

Authors:  Bárbara Bruna Ribeiro de Oliveira-Mendes; Carolina Campolina Rebello Horta; Anderson Oliveira do Carmo; Gabriela Lago Biscoto; Douglas Ferreira Sales-Medina; Hortênsia Gomes Leal; Pedro Ferreira Pinto Brandão-Dias; Sued Eustáquio Mendes Miranda; Carla Jeane Aguiar; Valbert Nascimento Cardoso; André Luis Branco de Barros; Carlos Chávez-Olortégui; M Fátima Leite; Evanguedes Kalapothakis
Journal:  Sci Rep       Date:  2018-10-03       Impact factor: 4.379

Review 9.  Forty Years of the Description of Brown Spider Venom Phospholipases-D.

Authors:  Luiza Helena Gremski; Hanna Câmara da Justa; Thaís Pereira da Silva; Nayanne Louise Costacurta Polli; Bruno César Antunes; João Carlos Minozzo; Ana Carolina Martins Wille; Andrea Senff-Ribeiro; Raghuvir Krishnaswamy Arni; Silvio Sanches Veiga
Journal:  Toxins (Basel)       Date:  2020-03-06       Impact factor: 4.546

10.  Antigenic and Substrate Preference Differences between Scorpion and Spider Dermonecrotic Toxins, a Comparative Investigation.

Authors:  Ramla Ben Yekhlef; Liza Felicori; Lucianna Helene Santos; Camila F B Oliveira; Raoudha Fadhloun; Elham Torabi; Delavar Shahbazzadeh; Kamran Pooshang Bagheri; Rafaela Salgado Ferreira; Lamia Borchani
Journal:  Toxins (Basel)       Date:  2020-10-01       Impact factor: 4.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.